Concepedia

Georg-Martin Haag

GH

Statistics

Publications

4

Citations

116

H-Index

4

Active since

2011

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

National Center for Tumor Diseases

Georg-Martin Haag is an author at Heidelberg University specializing in cancer therapeutics, medicine, and radiation oncology.

Top concepts

Publications per year

2011–2020

4

Publications

4

Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

Sylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag et al. · European Journal of Cancer · 2015 · 60 citations

, , +8

1421MO Final results and subgroup analysis of the PETRARCA randomized phase II AIO trial: Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma

S-E. Al-Batran, Georg-Martin Haag, Thomas J. Ettrich et al. · Annals of Oncology · 2020 · 26 citations · Full text

, , +8

Treatment of Long-Term Catheter-Related Bloodstream Infections with a Taurolidine Block: A Single Cancer Center Experience

Georg-Martin Haag, Anne-Katrin Berger, Dirk Jäger · The Journal of Vascular Access · 2011 · 15 citations

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer – the multinational MATEO study

Georg-Martin Haag, Gertraud Stocker, Julia Quidde et al. · BMC Cancer · 2017 · 15 citations · Full text

1–4 of 4